Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
Clinical trial NCT06603142 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06603142
- Sponsor
- Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2026-04-01
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.